Medopad raises $25M led by Bayer to develop biomarkers tracked via apps and wearables

November 10, 2019

Medopad, the U.K. startup that has been working with Tencent to develop AI-based methods for building and tracking “digital” biomarkers — measurable indicators of the progression of illnesses and diseases that are picked up not with blood samples or in-doctor visits but using apps and wearables — has announced another round of funding to expand the scope of its developments. The startup has picked up $25 million, led by pharmaceuticals…

Read More >>